References
- World Health Organization. Global Tuberculosis Report. Geneva: WHO; 2022 [cited 2023 Aug 15]. Available from: https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2022
- World Health Organization. WHO tuberculosis programme: framework for effective tuberculosis control. Geneva: WHO; 1994 [cited 2023 Aug 15]. Available from: https://apps.who.int/iris/handle/10665/58717
- World Health Organization. What is DOTS?: a guide to understanding the WHO-recommended TB control strategy known as DOTS. Geneva: WHO; 1999 [cited 2023 Aug 15]. Available from: https://apps.who.int/iris/handle/10665/65979
- Dalazoana SSV, Gabardo BMA, Cardoso RF. Challenges faced by health workers in the use of the directly observed treatment (DOT) for tuberculosis. Rev Inst Med Trop São Paulo. 2021;63:1–5. doi: 10.1590/s1678-9946202163025
- Wright CM, Westerkamp L, Korver S, Dobler CC. Community-based directly observed therapy (DOT) versus clinic DOT for tuberculosis: a systematic review and meta-analysis of comparative effectiveness. BMC Infect Dis. 2015;15:210. doi: 10.1186/s12879-015-0945-5
- World Health Organization. WHO tuberculosis country profile. Guinea Geneva: WHO; 2023 [cited 2023 Aug 15]. Available from: https://worldhealthorg.shinyapps.io/tb_profiles/?_inputs_&entity_type=%22country%22&lan=%22EN%22&iso2=%22GN%22
- Boozary AS, Farmer PE, Jha AK. The Ebola outbreak, fragile health systems, and quality as a cure. JAMA. 2014;312:1859–1860. doi: 10.1001/jama.2014.14387
- Ortuno-Gutierrez N, Zachariah R, Woldeyohannes D, Bangoura A, Chérif G, Loua F, et al. Upholding tuberculosis services during the 2014 Ebola storm: an encouraging experience from Conakry, Guinea. PLoS One. 2016;11:e0157296. doi: 10.1371/journal.pone.0157296
- National Tuberculosis Control Program of Guinea. National Strategic Plan for Tuberculosis Control 2016-2020. Conakry. 2016.
- Mohr E, Daniels J, Beko B, Isaakidis P, Cox V, Steele SJ, et al. DOT or SAT for rifampicin-resistant tuberculosis? A non-randomized comparison in a high HIV-prevalence setting. PLoS One. 2017;12:e0178054. doi: 10.1371/journal.pone.0178054
- McKay B, Castellanos M, Ebell M, Whalen CC, Handel A, Serra R. An attempt to reproduce a previous meta-analysis and a new analysis regarding the impact of directly observed therapy on tuberculosis treatment outcomes. PLoS One. 2019;14:e0217219. doi: 10.1371/journal.pone.0217219
- Tian JH, Lu ZX, Bachmann MO, Song FJ. Effectiveness of directly observed treatment of tuberculosis: a systematic review of controlled studies. Int J Tuberc Lung Dis. 2014;18:1092–1098. doi: 10.5588/ijtld.13.0867
- National Institute of Statistics of Guinea. General Census of Population and Housing in Guinea. Conakry. 2014.
- National Tuberculosis Control Program of Guinea. TB management guidance for health care workers. Conakry. 2015.
- World Health Organization. Definitions and reporting framework for tuberculosis – 2013 revision. ( updated December 2014 and January 2020). Geneva: WHO; 2014. Available from: https://apps.who.int/iris/bitstream/handle/10665/79199/9789241505345_eng.pdf;jsessionid=FF74F75B48C9E8100CA8B1E88C8DF744?sequence=1
- National Tuberculosis Control Program of Guinea. Tuberculosis annual activity report 2019. Conakry. 2020.
- Kurbaniyazova G, Msibi F, Bogati H, Kal M, Sofa A, Abdi Djama E, et al. TB treatment using family members, treatment supporters and self-administered therapies in rural Papua New Guinea. Public Health Action. 2023;13:60–64. doi: 10.5588/pha.22.0062
- Little KM, Msandiwa R, Martinson N, Golub J, Chaisson R, Dowdy D. Yield of household contact tracing for tuberculosis in rural South Africa. BMC Infect Dis. 2018;18:299. doi: 10.1186/s12879-018-3193-7
- Sejie GA, Mahomed OH. Mapping the effectiveness of the community tuberculosis care programs: a systematic review. Syst Rev. 2023;12. doi: 10.1186/s13643-023-02296-0
- World Health Organization. Information Note. Tuberculosis and COVID-19. COVID-19: considerations for tuberculosis (TB) care. Geneva: WHO; 2020 [cited 2023 Aug 15]. Available from: https://www.who.int/docs/default-source/hq-tuberculosis/covid-19-tb-clinical-management-info-note-dec-update-2020.pdf?sfvrsn=554b68a7_0
- Zimmer AJ, Heitkamp P, Malar J, Dantas C, O’Brien K, Pandita A, et al. Facility-based directly observed therapy (DOT) for tuberculosis during COVID-19: a community perspective. J Clin Tuberculosis Other Mycobacterial Dis. 2021;24:100248. doi: 10.1016/j.jctube.2021.100248
- Nguyen TA, Pham MT, Nguyen TL, Nguyen VN, Pham DC, Nguyen BH, et al. Video directly observed therapy to support adherence with treatment for tuberculosis in Vietnam: a prospective cohort study. Inter J Infect Dis. 2017;65:85–89. doi: 10.1016/j.ijid.2017.09.029